Universität zu Köln

Journal Article

Behringer, Karolin, Goergen, Helen, Mueller, Horst, Thielen, Indra, Brillant, Corinne, Kreissl, Stefanie, Halbsguth, Teresa Veronika, Meissner, Julia, Greil, Richard, Moosmann, Peter, Shonukan, Oluwatoyin, Rueffer, Jens Ulrich, Flechtner, Hans-Henning, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration. J. Clin. Oncol., 34 (36). S. 4329 - 4346. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Behringer, Karolin, Thielen, Indra, Mueller, Horst, Goergen, Helen, Eibl, Angelika, Rosenbrock, Johannes, Halbsguth, Teresa, Reiners, Katrin S., Diehl, Volker, Engert, Andreas and Borchmann, Peter (2011). Fertility and Gonadal Function After Treatment of Early Unfavorable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG). Blood, 118 (21). S. 199 - 200. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Boell, Boris, Behringer, Karolin, Goergen, Helen, Broeckelmann, Paul, von Tresckow, Bastian, Eichenauer, Dennis A., Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2014). Doxorubicin, Vinblastine and Dacarbazine with or without Bleomycin for Older Patients with Early Stage Favorable Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 Trials. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Boell, Boris, Borchmann, Peter and Diehl, Volker (2010). Emerging drugs for Hodgkin's lymphoma. Expert Opin Emerg. Drugs, 15 (4). S. 585 - 596. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1744-7623

Boell, Boris, Goergen, Helen, Arndt, Nils, Meissner, Julia, Krause, Stefan W., Schnell, Roland, von Tresckow, Bastian, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Behringer, Karalin, Klimm, Beate C., Naumann, Ralph, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2013). Relapsed Hodgkin Lymphoma in Older Patients: A Comprehensive Analysis From the German Hodgkin Study Group. J. Clin. Oncol., 31 (35). S. 4431 - 4442. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Boell, Boris, Goergen, Helen, Behringer, Karolin, Broeckelmann, Paul J., Hitz, Felicitas, Kerkhoff, Andrea, Greil, Richard, von Tresckow, Bastian, Eichenauer, Dennis A., Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. Blood, 127 (18). S. 2189 - 2193. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Borchmann, Peter, Eichenauer, Dennis A., Pluetschow, Annette, Haverkamp, Heinz, Kreissl, Stefanie, Fuchs, Michael, Soekler, Martin, Hellmuth, Johannes C., Meissner, Julia, Mathas, Stephan, Behringer, Karolin, Dietlein, Markus, Kobe, Carsten, Diehl, Volker and Engert, Andreas (2015). Targeted Beacopp Variants in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Borchmann, Peter, Engert, Andreas and Diehl, Volker (2011). CHEMOTHERAPY Hodgkin lymphoma-absence of evidence not evidence of absence! Nat. Rev. Clin. Oncol., 8 (11). S. 636 - 639. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1759-4774

Borchmann, Peter, Goergen, Helen, Kobe, Carsten, Lohri, Andreas, Greil, Richard, Eichenauer, Dennis A., Zijlstra, Josee M., Markova, Jana, Meissner, Julia, Feuring-Buske, Michaela, Huttmann, Andreas ORCID: 0000-0003-2230-3873, Dierlamm, Judith, Soekler, Martin, Beck, Hans-Joachim, Willenbacher, Wolfgang, Ludwig, Wolf-Dieter, Pabst, Thomas, Topp, Max S., Hitz, Felicitas, Bentz, Martin, Keller, Ulrich Bernd, Kuhnhardt, Dagmar, Ostermann, Helmut, Schmitz, Norbert, Hertenstein, Bernd, Aulitzky, Walter, Maschmeyer, Georg, Vieler, Tom, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Kuhnert, Georg, Diehl, Volker, Dietlein, Markus and Engert, Andreas (2017). PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet, 390 (10114). S. 2790 - 2803. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Borchmann, Peter, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Diehl, Volker, Cerny, Thomas, Markova, Jana, Ho, Anthony D., Eich, Hans-Theodor, Mueller-Hermelink, Hans Konrad, Kanz, Lothar, Greil, Richard, Rank, Andreas, Paulus, Ursula, Smardova, Lenka, Huber, Christoph, Doerken, Bernd, Nerl, Christoph, Krause, Stefan W., Mueller, Rolf-Peter, Fuchs, Michael and Engert, Andreas (2011). Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group. J. Clin. Oncol., 29 (32). S. 4234 - 4243. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 0732-183X

Borchmann, Peter, Haverkamp, Heinz, Lohri, Andreas, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Engel, Nicole, Keller, Ulrich, Maschmeyer, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2014). Addition of Rituximab to BEACOPP(escalated) to Improve the Outcome of Early Interim PET Positive Advanced Stage Hodgkin Lymphoma Patients: Second Planned Interim Analysis of the HD18 Study. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Borchmann, Peter, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Lohri, Andreas, Mey, Ulrich, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Ostermann, Helmut, Keller, Ulrich, Maschmeyer, Georg, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2017). Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP(escalated) alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group. Lancet Oncol., 18 (4). S. 454 - 464. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Borchmann, Peter, Moccia, Alden, Greil, Richard, Hertzberg, Mark, Schaub, Valdete, Huettmann, Andreas, Keil, Felix, Dierlamm, Judith, Haenel, Mathias, Novak, Urban, Meissner, Julia, Zimmermann, Andreas, Mathas, Stephan, Zijlstra, Josee M., Fossa, Alexander, Viardot, Andreas, Hertenstein, Bernd, Martin, Sonja, Giri, Pratyush, Kamper, Peter, Molin, Daniel, Kreissl, Stefanie, Fuchs, Michael, Schneider, Gundolf, Rosenwald, Andreas, Klapper, Wolfram, Eich, Hans, Baues, Christian, Hallek, Michael, Dietlein, Markus, Kobe, Carsten, Diehl, Volker and Engert, Andreas (2022). Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group. Blood, 140. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Broeckelmann, Paul J., Goergen, Helen, Fuchs, Michael, Kriz, Jan, Semrau, Robert, Baues, Christian, Kobe, Carsten, Behringer, Karolin, Eichenauer, Dennis A., von Tresckow, Bastian, Klimm, Beate, Halbsguth, Teresa, Wongso, Diana, Pluetschow, Annette, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Dietlein, Markus, Eich, Hans T., Stein, Harald, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2015). Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group. Br. J. Haematol., 171 (4). S. 547 - 557. HOBOKEN: WILEY. ISSN 1365-2141

Diehl, Volker and Borchmann, Peter (2014). Hodgkin Lymphoma Preface. Hematol. Oncol. Clin. North Am., 28 (1). S. IX - 2. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1558-1977

Eich, Hans Theodor, Diehl, Volker, Goergen, Helen, Pabst, Thomas, Markova, Jana, Debus, Juergen, Ho, Anthony, Doerken, Bernd, Rank, Andreas, Grosu, Anca-Ligia, Wiegel, Thomas, Karstens, Johann Hinrich, Greil, Richard, Willich, Normann, Schmidberger, Heinz, Doehner, Hartmut, Borchmann, Peter, Mueller-Hermelink, Hans-Konrad, Mueller, Rolf-Peter and Engert, Andreas (2010). Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial. J. Clin. Oncol., 28 (27). S. 4199 - 4207. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Eichenauer, Dennis A., Boell, Boris and Diehl, Volker (2014). Pharmacotherapy of Hodgkin lymphoma: standard approaches and future perspectives. Expert Opin. Pharmacother., 15 (8). S. 1139 - 1152. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1744-7666

Eichenauer, Dennis A., Haverkamp, Heinz, Behringer, Karolin, Halbsguth, Teresa, Fuchs, Michael, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2010). Secondary MDS/AML In Hodgkin Lymphoma Patients Treated within German Hodgkin Study Group (GHSG) Clinical Trials After Introduction of the BEACOPP Protocol. Blood, 116 (21). S. 1105 - 1107. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Muller, Horst, Elger, Leonard, Goergen, Helen, Fuchs, Michael, Kreissl, Stefanie, Boll, Boris, Diehl, Volker, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2021). Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group. Br. J. Haematol., 193 (3). S. 515 - 520. HOBOKEN: WILEY. ISSN 1365-2141

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Behringer, Karolin, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2014). Treatment of Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): An Analysis from the German Hodgkin Study Group (GHSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Sasse, Stephanie, Baues, Christian, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2020). Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group. J. Clin. Oncol., 38 (7). S. 698 - 707. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, von Tresckow, Bastian, Boell, Boris, Behringer, Karolin, Diehl, Volker, Eich, Hans Theodor, Borchmann, Peter and Engert, Andreas (2015). Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group. J. Clin. Oncol., 33 (26). S. 2857 - 2865. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Eichenauer, Dennis A., Pluetschow, Annette, Kreissl, Stefanie, Soekler, Martin, Hellmuth, Johannes C. ORCID: 0000-0001-8409-3037, Meissner, Julia, Mathas, Stephan, Topp, Max S., Behringer, Karolin, Klapper, Wolfram, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2017). Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. Lancet Oncol., 18 (12). S. 1680 - 1688. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Eichenauer, Dennis A., Pluetschow, Annette, Schroeder, Lena, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2018). Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group. Blood, 132 (14). S. 1519 - 1526. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Pluetschow, Annette, Schroeder, Lena, Fuchs, Michael, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2016). Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: An Analysis from the German Hodgkin Study Group (GHSG). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Thielen, Indra, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Franklin, Jeremy ORCID: 0000-0003-1536-0925, Behringer, Karolin, Halbsguth, Teresa, Klimm, Beate, Diehl, Volker, Sasse, Stephanie, Rothe, Achim, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2014). Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood, 123 (11). S. 1658 - 1665. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Engert, Andreas, Haverkamp, Heinz, Kobe, Carsten, Markova, Jana, Renner, Christoph, Ho, Anthony D., Zijlstra, Josee, Kral, Zdenek, Stein, Harald, Eich, Hans Theodor, Mueller, Rolf-Peter, Dietlein, Markus, Borchmann, Peter and Diehl, Volker (2011). Reduced Intensity of Chemotherapy and PET-Guided Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma: The GHSG HD15 Final Results. Blood, 118 (21). S. 271 - 272. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Engert, Andreas, Kobe, Carsten, Haverkamp, Heinz, Kuhnert, Georg, Markova, Jana, Lohri, Andreas, Klutmann, Susanne, Amthauer, Holger, Diehl, Volker, Borchmann, Peter and Dietlein, Markus (2012). Relative Reduction of Residual Tumor Improves Outcome Prediction of PET After Effective Chemotherapy for Patients with Advanced Stage Hodgkin Lymphoma. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Eich, Hans, Baues, Christian, Greil, Richard, Sasse, Stephanie, Zijlstra, Josee M., Lohri, Andreas, Rosenwald, Andreas, von Tresckow, Bastian, Diehl, Volker, Kuhnert, Georg, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2018). PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schaefer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josee M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Duehrsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2019). Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. J. Clin. Oncol., 37 (31). S. 2835 - 2847. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Halbsguth, Teresa V., Boell, Boris, Borchmann, Peter and Diehl, Volker (2011). The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma. Curr. Hematol. Malig. Rep., 6 (3). S. 164 - 172. PHILADELPHIA: CURRENT MEDICINE GROUP. ISSN 1558-822X

Halbsguth, Teresa V., Nogova, Lucia, Mueller, Horst, Sieniawski, Michal, Eichenauer, Dennis A., Schober, Thomas, Nisters-Backes, Hiltrud, Borchmann, Peter, Diehl, Volker, Engert, Andreas and Josting, Andreas (2010). Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood, 116 (12). S. 2026 - 2033. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Borchmann, Peter, Diehl, Volker, Engert, Andreas and von Tresckow, Bastian (2015). Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials. J. Clin. Oncol., 33 (22). S. 2430 - 2440. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Josting, Andreas, Mueller, Horst, Borchmann, Peter, Baars, Joke W., Metzner, Bernd ORCID: 0000-0002-1496-1377, Doehner, Hartmut, Aurer, Igor, Smardova, Lenka, Fischer, Thomas, Niederwieser, Dietger, Schaefer-Eckart, Kerstin, Schmitz, Norbert, Sureda, Anna, Glossmann, Jan, Diehl, Volker, DeJong, Daphne, Hansmann, Martin-Leo, Raemaekers, John and Engert, Andreas (2010). Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma. J. Clin. Oncol., 28 (34). S. 5074 - 5081. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Klimm, Beate, Franklin, Jeremy ORCID: 0000-0003-1536-0925, Stein, Harald, Eichenauer, Dennis A., Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Diehl, Volker, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2011). Lymphocyte-Depleted Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group. J. Clin. Oncol., 29 (29). S. 3914 - 3921. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Klimm, Beate, Goergen, Helen, Fuchs, Michael, von Tresckow, Bastian, Diehl, Volker, Eich, Hans Theodor, Engert, Andreas and Borchmann, Peter (2012). Discrimination of an Early Unfavorable Risk Group Has Significant Impact On Treatment Outcome in Early-Stage Hodgkin Lymphoma: An Analysis of International Staging Definitions and Risk Factors. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Kobe, Carsten, Kuhnert, Georg, Kahraman, Deniz, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Eich, Hans-Theodor, Franke, Mareike, Persigehl, Thorsten, Klutmann, Susanne, Amthauer, Holger, Bockisch, Andreas, Kluge, Regine, Wolf, Hans-Heinrich, Maintz, David, Fuchs, Michael, Borchmann, Peter, Diehl, Volker, Drzezga, Alexander, Engert, Andreas and Dietlein, Markus (2014). Assessment of Tumor Size Reduction Improves Outcome Prediction of Positron Emission Tomography/Computed Tomography After Chemotherapy in Advanced-Stage Hodgkin Lymphoma. J. Clin. Oncol., 32 (17). S. 1776 - 1782. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kreissl, Stefanie, Goergen, Helen, von Tresckow, Bastian, Behringer, Karolin, Markova, Jana, Lohri, Andreas, Meissner, Julia, Zijlstra, Josee M., Greil, Richard, Topp, Max S., Soekler, Martin, Doehner, Hartmut, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2015). Primary Progressive Disease in Hodgkin Lymphoma Patients: A Retrospective Analysis from the German Hodgkin Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kreissl, Stefanie, Mueller, Horst, Goergen, Helen, Mayer, Axel, Brillant, Corinne, Behringer, Karolin, Halbsguth, Teresa Veronika, Hitz, Felicitas, Soekler, Martin, Shonukan, Oluwatoyin, Rueffer, Jens Ulrich, Flechtner, Hans-Henning, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group. Lancet Oncol., 17 (10). S. 1453 - 1463. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Kreissl, Stefanie, Mueller, Horst, Goergen, Helen, Meissner, Julia, Topp, Max, Soekler, Martin, Markova, Jana, Bernhard, Jurg, Greil, Richard, von Tresckow, Bastian, Behringer, Karolin, Rueffer, Jens-Ulrich, Flechtner, Hans-Henning, Moestl, Michaela, Fuchs, Michael, Engert, Andreas, Diehl, Volker and Borchmann, Peter (2020). Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group. J. Clin. Oncol., 38 (25). S. 2839 - 2857. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kreissl, Stefanie, Mueller, Horst, Mayer, Axel, Behringer, Karolin, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2014). Fatigue in Hodgkin Lymphoma Patients: Longitudinal Evaluation and Curve Types up to 5 Years. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kreissl, Stefanie, Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Kaul, Helen, Buehnen, Ina, Mettler, Jasmin, Pabst, Thomas, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Fuchs, Michael, Diehl, Volker, Dietlein, Markus, Engert, Andreas, Borchmann, Peter and Kobe, Carsten . Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma. Br. J. Haematol.. HOBOKEN: WILEY. ISSN 1365-2141

Kreissl, Stefanie, von Tresckow, Bastian, Goergen, Helen, Haverkamp, Heinz, Sasse, Stephanie, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Beacoppescalated Followed By Radiotherapy of Initial Bulk or Residual Disease in Advanced Stage Hodgkin Lymphoma: Long-Term Follow up of the HD9 and HD12 Trials of the German Hodgkin Study Group. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Lawler, Mark, Banks, Ian, Law, Kate, Albreht, Tit, Armand, Jean-Pierre, Barbacid, Mariano, Barzach, Michele, Bergh, Jonas, Cameron, David, Conte, Pierfranco, de Braud, Filippo, de Gramont, Aimery, de Lorenzo, Francesco, Diehl, Volker, Diler, Sarper, Erdem, Sema, Geissler, Jan, Gore-Booth, Jola, Henning, Geoffrey, Hojgaard, Liselotte, Horgan, Denis, Jassem, Jacek ORCID: 0000-0002-8875-6747, Johnson, Peter, Kaasa, Stein, Kapitein, Peter, Karjalainen, Sakari, Kelly, Joan, Kienesberger, Anita, La Vecchia, Carlo, Lacombe, Denis, Lindahl, Tomas, Loewenberg, Bob, Luzzatto, Lucio, Malby, Rebecca, Mastris, Ken, Meunier, Francoise, Murphy, Martin, Naredi, Peter ORCID: 0000-0002-5652-0422, Nurse, Paul, Oliver, Kathy, Pearce, Jonathan, Pelouchov, Jana, Piccart, Martine, Pinedo, Bob, Spurrier-Bernard, Gilly, Sullivan, Richard ORCID: 0000-0002-6435-1825, Tabernero, Josep ORCID: 0000-0002-2495-8139, Van de Velde, Cornelis, Van Herk, Bert, Vedsted, Peter ORCID: 0000-0003-2113-5599, Waldmann, Anita, Weller, David, Wilking, Nils, Wilson, Roger, Yared, Wendy, Zielinski, Christoph, Hausen, Harald Zur, Le Chevalier, Thierry, Johnston, Patrick and Selby, Peter (2016). The European Cancer Patient's Bill of Rights, update and implementation 2016. ESMO Open, 1 (6). LONDON: BMJ PUBLISHING GROUP. ISSN 2059-7029

Sasse, Stephanie, Broeckelmann, Paul J., Goergen, Helen, Pluetschow, Annette, Mueller, Horst, Kreissl, Stefanie, Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Diehl, Volker and Engert, Andreas (2017). Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials. J. Clin. Oncol., 35 (18). S. 1999 - 2009. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Stein, Harald and Diehl, Volker (2014). First Hodgkin Cell Line L428 and the CD30 Antigen Their Role for Diagnostic and Treatment of CD30-positive Neoplasms. Hematol. Oncol. Clin. North Am., 28 (1). S. 1 - 13. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1558-1977

Venkataraman, Girish, Mirza, M. Kamran, Eichenauer, Dennis A. and Diehl, Volker (2014). Current status of prognostication in classical Hodgkin lymphoma. Br. J. Haematol., 165 (3). S. 287 - 300. HOBOKEN: WILEY. ISSN 1365-2141

von Tresckow, Bastian and Diehl, Volker (2014). An update on emerging drugs for Hodgkin lymphoma. Expert Opin Emerg. Drugs, 19 (2). S. 215 - 225. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1744-7623

von Tresckow, Bastian, Kreissl, Stefanie, Goergen, Helen, Brockelmann, Paul J., Pabst, Thomas, Fridrik, Michael, Rummel, Mathias, Jung, Wolfram, Thiemer, Julia, Sasse, Stephanie, Burkle, Carolin, Baues, Christian, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2018). Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials. Lancet Haematol., 5 (10). S. E462 - 12. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026